Akros Pharma Inc.
Quick facts
Phase 3 pipeline
- Placebo for comparator
This drug has no known mechanism of action.
Phase 2 pipeline
- JTE-451 Tablets · Immunology
JTE-451 is a selective antagonist of the P2X7 receptor, which modulates immune cell activation and inflammatory responses. - JTT-130
- JTT-302
- JTT-851
- JTT-861 Capsules
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Akros Pharma Inc.
What is Akros Pharma Inc.'s pipeline?
Akros Pharma Inc. has 1 drugs in Phase 3, 5 in Phase 2, 5 in Phase 1. Late-stage candidates include Placebo for comparator.
Related
- Sector hub: All tracked pharma companies